Sarepta Therapeutics
SRPT
$130.58
Share price
-1.45%
Change (1 day)
-16.93%
Change (1 year)
Categories
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.
Sarepta Therapeutics (SRPT) - P/B ratio
P/B ratio as of May 2024 : 13.0
According to Sarepta Therapeutics
's latest financial reports the company has a price-to-book ratio of 13.0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Sarepta Therapeutics - P/B ratio (from 2001 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 10.5 | -64.47% |
| 2022-12-31 | 29.5 | 249.71% |
| 2021-12-31 | 8.45 | -52.16% |
| 2020-12-31 | 17.7 | 48.95% |
| 2019-12-31 | 11.9 | 57.82% |
| 2018-12-31 | 7.51 | 64.9% |
| 2017-12-31 | 4.56 | 2.45% |
| 2016-12-31 | 4.45 | -51.91% |
| 2015-12-31 | 9.25 | 283.15% |
| 2014-12-31 | 2.41 | -22.41% |
| 2013-12-31 | 3.11 | -52.96% |
| 2012-12-31 | 6.61 | 102.84% |
| 2011-12-31 | 3.26 | -103.86% |
| 2010-12-31 | -84.6 | -1338.5% |
| 2009-12-31 | 6.83 | 129.38% |
| 2008-12-31 | 2.98 | -13.59% |
| 2007-12-31 | 3.44 | -23.19% |
| 2006-12-31 | 4.48 | 36.28% |
| 2005-12-31 | 3.29 | 1.78% |
| 2004-12-31 | 3.23 | 0.02% |
| 2003-12-31 | 3.23 | -42.85% |
| 2002-12-31 | 5.66 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | 3.67 | -71.84% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | -2.89 | -122.16% | 🇺🇸 USA |
 Novavax NVAX | -2.65 | -120.34% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -85.0 | -752.57% | 🇺🇸 USA |
 Insmed INSM | -11.2 | -185.66% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | -2.88 | -122.11% | 🇺🇸 USA |
 Avidity Biosciences RNA | 5.64 | -56.75% | 🇺🇸 USA |